Background and Aims
Since its market release, gabapentin has been presumed to have no
abuse potential and subsequently has been prescribed widely off-label,
despite increasing reports of gabapentin misuse. This review estimates and
describes the prevalence and effects of, motivations behind, and risk
factors for gabapentin misuse, abuse, and diversion.
Methods
Databases were searched for peer-reviewed articles demonstrating
gabapentin misuse, characterized by taking a larger dosage than prescribed
or taking gabapentin without a prescription, and diversion. All types of
studies were considered; grey literature was excluded. Thirty-three articles
met inclusion criteria, consisting of 23 case studies and 11 epidemiological
reports. Published reports came from the USA, the UK, Germany, Finland,
India, South Africa, and France, and two analyzed websites not specific to a
particular country.
Results
Prevalence of gabapentin misuse in the general population was
reported to be 1%, 40–65% among individuals with
prescriptions, and between 15–22% within populations of
people who abuse opioids. An array of subjective experiences reminiscent of
opioids, benzodiazepines, and psychedelics were reported over a range of
doses, including those within clinical recommendations. Gabapentin was
primarily misused for recreational purposes, self-medication, or intentional
self-harm and was misused alone or in combination with other substances,
especially opioids, benzodiazepines, and/or alcohol. Individuals with
histories of drug abuse were most often involved in its misuse.
Conclusions
Epidemiological and case report evidence suggests that the
antiepileptic and analgesic medication gabapentin is being misused
internationally at a rate of about 1%, with substance abuse
populations at special risk for misuse/abuse.